Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-02
DOI
10.1186/s13195-019-0553-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Target Engagement in an Alzheimer Trial: Crenezumab Lowers Aβ Oligomers in CSF
- (2019) Ting Yang et al. ANNALS OF NEUROLOGY
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
- (2018) Devendra Kumar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drug development for Alzheimer’s disease: review
- (2018) Kejing Lao et al. JOURNAL OF DRUG TARGETING
- Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice
- (2018) Angie C.A. Chiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
- (2018) Judite R. M. Coimbra et al. Frontiers in Chemistry
- Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
- (2018) Bernd Bohrmann et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)
- (2018) Stephen Salloway et al. Alzheimers Research & Therapy
- Validation of an MRI Rating Scale for Amyloid-Related Imaging Abnormalities
- (2017) Arianne Bechten et al. JOURNAL OF NEUROIMAGING
- Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease
- (2017) Xuan Ye et al. JOURNAL OF NEUROSCIENCE
- Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ
- (2017) Lotta Agholme et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease
- (2017) Claire E. Le Pichon et al. Science Translational Medicine
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease
- (2016) Katherine R. Sadleir et al. ACTA NEUROPATHOLOGICA
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Brain Amyloid-β Plays an Initiating Role in the Pathophysiological Process of the PS1V97L-Tg Mouse Model of Alzheimer’s Disease
- (2016) Wei Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer’s mouse model
- (2016) Carla M. Yuede et al. JOURNAL OF CELL BIOLOGY
- Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
- (2016) Ting Yang et al. JOURNAL OF NEUROSCIENCE
- Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice
- (2016) Ksenia V. Kastanenka et al. JOURNAL OF NEUROSCIENCE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
- (2016) Mark Ultsch et al. Scientific Reports
- Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
- (2016) Thomas J. Esparza et al. Scientific Reports
- Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
- (2015) Carlo Condello et al. Nature Communications
- Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer’s Disease and Cerebral Amyloid Angiopathy
- (2015) Jacopo C. DiFrancesco et al. Frontiers in Neurology
- A Death Receptor 6-Amyloid Precursor Protein Pathway Regulates Synapse Density in the Mature CNS But Does Not Contribute to Alzheimer's Disease-Related Pathophysiology in Murine Models
- (2014) D. Y. Kallop et al. JOURNAL OF NEUROSCIENCE
- Genetic Modulation of Soluble A Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease
- (2014) S. W. Fowler et al. JOURNAL OF NEUROSCIENCE
- Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
- (2014) William F Goure et al. Alzheimers Research & Therapy
- The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
- (2013) Patty C. Kandalepas et al. ACTA NEUROPATHOLOGICA
- Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
- (2013) L. Mucke et al. Cold Spring Harbor Perspectives in Medicine
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
- (2013) C. L. Masters et al. Cold Spring Harbor Perspectives in Medicine
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Brain Oligomeric β-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice
- (2011) Bibiana DaRocha-Souto et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Amyloid oligomers: formation and toxicity of Aβ oligomers
- (2010) Masafumi Sakono et al. FEBS Journal
- Amyloid Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation
- (2010) H.-Y. Wu et al. JOURNAL OF NEUROSCIENCE
- Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice
- (2010) Tobias Bittner et al. PLoS One
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Oligomeric amyloid associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
- (2009) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dynamics of A Turnover and Deposition in Different -Amyloid Precursor Protein Transgenic Mouse Models Following -Secretase Inhibition
- (2008) D. Abramowski et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
- (2008) Melanie Meyer-Luehmann et al. NATURE
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Expression of Transgenic APP mRNA Is the Key Determinant for Beta-Amyloid Deposition in PS2APP Transgenic Mice
- (2008) Laurence Ozmen et al. Neurodegenerative Diseases
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started